8-K
Current Report
Axsome Therapeutics, Inc. Filed Acc 0000950170-23-027059
Executive or director change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading axsm-20230602.htm…